WFI Healthcare Agency
September 2026
Steve Kim, Managing Partner

A Korean American Family in New Jersey: A Realistic Example

A 67-year-old Korean American man living in New Jersey was recently diagnosed with a blood cancer. His doctor recommended a hematopoietic stem cell transplant, also commonly referred to as a bone marrow transplant.

His family had seen advertisements for stem cell injections for knee arthritis and back pain and assumed that all stem cell treatments were essentially the same.

They are not.

A stem cell transplant used to treat blood cancer is very different from a stem cell injection marketed for arthritis, back pain, or anti-aging.

For a Medicare beneficiary like this patient, a medically necessary hematopoietic stem cell transplant may be covered when Medicare requirements are met. On the other hand, many unapproved regenerative medicine treatments marketed for joint pain are not covered as standard Medicare benefits.

This distinction is extremely important before agreeing to treatment.

How Far Has Stem Cell Therapy Come in the United States?

Stem cell research is advancing rapidly, but not every treatment advertised as stem cell therapy is FDA approved.

The FDA regulates cellular and gene therapy products in the United States. Its approved products include several CAR-T cell therapies and other cellular therapies used for specific medical conditions.

However, FDA approval for one cellular therapy does not mean that all stem cell treatments are approved.

The FDA has specifically warned consumers about unapproved regenerative medicine products marketed for conditions such as arthritis, back pain, joint problems, neurological diseases, and other conditions.

Therefore, patients should distinguish between different types of cellular therapies.

Hematopoietic Stem Cell Transplantation

Hematopoietic stem cell transplantation is an established treatment for certain blood cancers and blood disorders, including leukemia, lymphoma, and multiple myeloma.

CAR-T Cell Therapy

CAR-T is a type of cellular immunotherapy used for certain blood cancers. Several CAR-T products have received FDA approval for specific diseases and patient populations.

CAR-T should not simply be classified as the same treatment as an unapproved stem cell injection.

Stem Cell Injections for Arthritis or Back Pain

Stem cell injections marketed for knee arthritis, disc disease, shoulder pain, or other musculoskeletal conditions are a very different category.

The FDA has warned that many products marketed for these purposes are not FDA-approved treatments.

Patients should be particularly cautious when a clinic promises that a stem cell injection will regenerate cartilage, cure arthritis, or eliminate chronic pain.

Does Medicare Cover Stem Cell Therapy?

The short answer is sometimes, but not all stem cell treatments are covered.

Medicare covers certain stem cell and bone marrow transplants when specific coverage requirements are met.

CMS has a National Coverage Determination addressing stem cell transplantation. Coverage depends on factors such as the medical condition, type of transplant, medical necessity, and applicable Medicare requirements.

Medicare.gov also explains that Part A and Part B may cover certain stem cell and bone marrow transplant services when the requirements are satisfied.

For example, a medically necessary hematopoietic stem cell transplant for certain blood cancers may be covered.

However, this does not mean that Medicare automatically covers every procedure described by a provider as stem cell therapy.

Generally Different Situations

Stem cell transplant for certain blood cancers

May be covered when Medicare coverage requirements are met.

Autologous stem cell transplant for certain cancers

May be covered when the treatment meets Medicare requirements.

Stem cell injections for knee arthritis

Generally not covered as a standard Medicare stem cell transplant benefit when the treatment is an unapproved regenerative procedure.

Stem cell treatment for anti-aging or wellness

Not covered as a standard medically necessary Medicare treatment.

The key point is that FDA approval alone is not the only factor. Medicare coverage rules and medical necessity must also be considered.

What Could the Patient Pay Under Medicare?

Even when a stem cell transplant is covered, the patient may still have out-of-pocket costs.

For 2026, the Medicare Part A inpatient hospital deductible is $1,736.

The standard Medicare Part B monthly premium for 2026 is $202.90, and the annual Part B deductible is $283.

For covered Part B services, beneficiaries generally pay 20 percent of the Medicare-approved amount after meeting the Part B deductible.

The actual financial responsibility can be very different depending on whether the patient has Original Medicare alone, a Medigap policy, or a Medicare Advantage plan.

Medicare Advantage members should also check whether the transplant center and physicians are in-network and whether prior authorization is required.

Before treatment, patients should ask the insurance plan for a written explanation of coverage and expected patient responsibility.

What About New Jersey ACA or Obamacare Plans?

New Jersey residents who purchase health insurance through the ACA Marketplace should also understand an important distinction.

An ACA plan does not automatically cover every treatment that uses the term stem cell therapy.

Medically necessary bone marrow and hematopoietic stem cell transplantation may be covered under applicable New Jersey health insurance requirements and the specific plan’s benefits.

New Jersey individual health insurance regulations include provisions concerning certain bone marrow and peripheral blood stem cell transplantation procedures.

However, coverage can depend on the specific diagnosis, treatment, facility, network status, medical necessity, and plan requirements.

This means an ACA member should never assume that a treatment is covered simply because a doctor or clinic calls it stem cell therapy.

What About Clinical Trials?

Clinical trials require another level of caution.

Participating in a clinical trial does not automatically mean that all treatment costs are free.

Medicare can cover certain routine costs associated with qualifying clinical trials.

Routine costs may include services that Medicare would normally cover even outside the clinical trial, as well as certain medically necessary services associated with monitoring and treating complications.

However, the investigational treatment itself may not be covered in the same way as routine patient care.

New Jersey health insurance rules also contain protections concerning certain routine patient costs associated with qualifying clinical trials.

Before entering a clinical trial, patients should ask both the research institution and their insurance company:

Which costs are covered by insurance?

Which costs are paid by the clinical trial sponsor?

Which costs could become the patient’s responsibility?

Get the answers in writing whenever possible.

Seven Questions to Ask Before Receiving Stem Cell Therapy

If a doctor or clinic recommends stem cell therapy, ask these questions before signing a treatment agreement.

1. What exact type of cellular or stem cell therapy is being recommended?

2. Is this treatment FDA approved for my specific medical condition?

3. Is this standard medical treatment or part of a clinical trial?

4. Does my Medicare or NJ ACA plan cover this specific treatment?

5. Does the insurance company require prior authorization?

6. Is the hospital or treatment center in my insurance network?

7. How much will I personally have to pay if insurance does not cover the treatment?

Be especially careful if a clinic tells you that insurance will pay for everything, the treatment is FDA approved, or the treatment is free because it is a clinical trial.

Do not rely solely on verbal statements. Confirm the information with the insurance company, the FDA, and the clinical trial institution when appropriate.

The Bottom Line for Medicare and ACA Members

The words stem cell therapy can describe very different medical procedures.

A hematopoietic stem cell transplant for certain blood cancers is not the same as a stem cell injection marketed for knee arthritis or back pain.

Medicare may cover certain medically necessary stem cell and bone marrow transplants when Medicare requirements are satisfied.

New Jersey ACA plans may also cover certain medically necessary transplantation services and applicable routine costs associated with qualifying clinical trials.

However, unapproved regenerative medicine treatments should not be assumed to be covered by Medicare or ACA insurance.

The safest approach is simple.

Before receiving treatment, confirm the exact procedure, diagnosis, FDA status, network status, prior authorization requirements, and your expected out-of-pocket cost.

For Korean American families in New Jersey, understanding the difference between an established medical treatment and an unapproved regenerative procedure can potentially prevent a very expensive surprise medical bill.

WFI Healthcare Agency helps Medicare and New Jersey ACA members better understand their health insurance coverage and options.

This article is for general educational purposes only and does not constitute medical, legal, or insurance advice. Coverage is determined by the patient’s specific insurance plan, medical condition, treatment, medical necessity, network status, and applicable coverage requirements.